Clinical presentation of pseudomyxoma peritonei

Scandinavian Journal of Surgery

Volumn 99, Issue 4, 2010, Pages 213-216

  Jarvinen P ^a   Lepisto A ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Chief complaint; Diagnosis; Examination; HIPEC; Indication for surgery; Pseudomyxoma peritonei; Signs; Surgery; Symptoms; Sytoreductive surgery

Indexed keywords

EID: 78650817985     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749691009900406     Document Type: Article

References (20)

1. Smeenk RM, van Velthuysen ML, Verwaal VJ, et al: Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol 2008;34:196-201
2. Sugarbaker PH, Ronnett BM, Archer A, et al: Pseudomyxoma peritonei syndrome. Adv Surg 1996;30:233-280
3. Hinson FL, Ambrose NS: Pseudomyxoma peritonei. Br J Surg 1998;85:1332-1339
4. Järvinen P, Järvinen HJ, Lepistö A: Survival of patients with pseudomyxoma peritonei treated by serial debulking. Colorectal Dis 2010;12:868-872
5. Gough DB, Donohue JH, Schutt AJ, et al: Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg 1994;219:112-119
6. Miner TJ, Shia J, Jaques DP, et al: Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg 2005;241:300-308
7. Sugarbaker PH: Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol 2001;27:239-243
8. Sugarbaker PH: Peritonectomy procedures. Cancer Treat Res 2007;134:247-264
9. Sugarbaker PH: Carcinomatosis from gastrointestinal cancer. Ann Med 2004;36:9-22
10. Elias D, Honore C, Ciuchendea R, et al: Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Br J Surg 2008;95:1164-1171
11. Schomas DA, Miller RC, Donohue JH, et al: Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience. Ann Surg 2009;249:588-595
12. Smeenk RM, Verwaal VJ, Antonini N, et al: Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg 2007;245:104-109
13. Sugarbaker PH, Chang D: Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999;6:727-731
14. Ronnett BM, Zahn CM, Kurman RJ, et al: Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol 1995;19:1390-1408
15. Bechtold RE, Chen MY, Loggie BW, et al: CT appearance of disseminated peritoneal adenomucinosis. Abdom Imaging 2001;26:406-410
16. Carmignani CP, Hampton R, Sugarbaker CE, et al: Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix. J Surg Oncol 2004;87:162-166
17. Esquivel J, Sugarbaker PH: Clinical presentation of the Pseudomyxoma peritonei syndrome. Br J Surg 2000;87:1414-1418
18. Elias D, Gilly F, Quenet F, et al: Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol; 36:456-462
19. Yan TD, Black D, Savady R, et al: A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol 2007;14:484-492
20. Saxena A, Yan TD, Chua TC, et al: Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol; 17:1291-1301